Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-68,850
Closed -$792K 8
2016
Q4
$792K Sell
68,850
-91,150
-57% -$1.09M 0.2% 5
2016
Q3
$1.82M Hold
160,000
0.51% 5
2016
Q2
$1.79M Sell
160,000
-23,000
-13% -$318K 0.73% 5
2016
Q1
$2.56M Sell
183,000
-113,562
-38% -$1.22M 2.03% 3
2015
Q4
$3.02M Hold
296,562
1.44% 3
2015
Q3
$4.86M Hold
296,562
2.57% 3
2015
Q2
$7M Hold
296,562
4.83% 3
2015
Q1
$7.29M Hold
296,562
6.12% 3
2014
Q4
$8.54M Hold
296,562
8.86% 3
2014
Q3
$10.2M Sell
296,562
-21,300
-7% -$950K 11.87% 3
2014
Q2
$16.9M Hold
317,862
12.67% 3
2014
Q1
$18.9M Hold
317,862
14.8% 3
2013
Q4
$28.9M Sell
317,862
-102,868
-24% -$9.94M 21.33% 3
2013
Q3
$39.1M Hold
420,730
5.52% 6
2013
Q2
$52.9M Buy
+420,730
New +$54.3M 7.17% 5

Other funds holding VVUS

Meditor Group's VVUS Position: Q1 2017 in Review

Meditor Group sold out of Vivus Inc (VVUS) in Q1 2017, closing a stake of 68,850 shares — an estimated $792K sold.

Meditor Group first reported a position in VVUS in Q2 2013 and held it in 15 quarters. The position peaked at $52.9M in Q2 2013. 78 funds tracked by Wall St. Rank hold VVUS as of Q1 2017.

  • Meditor Group reported no remaining Vivus Inc position as of Q1 2017 after selling out during the quarter.
  • Meditor Group sold 68,850 Vivus Inc shares in Q1 2017, an estimated $792K.
  • Meditor Group first reported a position in Vivus Inc in Q2 2013 and held it in 15 quarters.
  • Meditor Group's Vivus Inc position peaked at $52.9M in Q2 2013.
  • 78 funds tracked by Wall St. Rank held Vivus Inc as of Q1 2017.

Based on Meditor Group's 13F filing for Q1 2017, filed 24 Apr 2017.